MARKET

PVCT

PVCT

Provectus Biopha
OTCMQB
0.110
-0.004
-3.51%
Closed 15:51 12/04 EST
OPEN
0.114
PREV CLOSE
0.114
HIGH
0.114
LOW
0.109
VOLUME
282.10K
TURNOVER
31.47K
52 WEEK HIGH
0.221
52 WEEK LOW
0.045
MARKET CAP
46.27M
P/E (TTM)
-15.2917
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PVCT last week (1125-1129)?
Weekly Report · 3d ago
Weekly Report: what happened at PVCT last week (1118-1122)?
Weekly Report · 11/25 10:10
Weekly Report: what happened at PVCT last week (1111-1115)?
Weekly Report · 11/18 10:09
Based on the provided financial report articles, I generated the title for the article: "PVCT's Q3 2024 Financial Report: Non-Related Party Transactions, Related Party Transactions, and Stock Information" Please note that the title may not be exact, as the provided text is a financial report and may not contain a clear title.
Press release · 11/16 18:41
Provectus Pharmaceuticals to Reveal Key 2024 Updates
TipRanks · 11/14 13:32
Provectus Biopharmaceuticals GAAP EPS of $0.00, revenue of $0.11M
Seeking Alpha · 11/14 13:14
Here's the major earnings before the open tomorrow
Seeking Alpha · 11/13 23:00
Here are the major earnings after the close today
Seeking Alpha · 11/13 15:00
More
About PVCT
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform comprises a range of different drug product candidates and preclinical pharmaceutical-grade RBS formulations using different concentrations and delivered by different routes of administration specific to each disease area and/or indication. The Company’s HX medical science platform includes clinical development programs in oncology, dermatology, and ophthalmology; in vivo proof-of-concept drug discovery programs in oncology, hematology, wound healing, and animal health, and in vitro drug discovery programs in infectious diseases and tissue regeneration and repair.

Webull offers Provectus Biopharmaceuticals Inc stock information, including OTCMQB: PVCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PVCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PVCT stock methods without spending real money on the virtual paper trading platform.